Literature DB >> 21281785

Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer.

Jun Nakamura1, Yoshihiko Kitajima, Keita Kai, Kazuyoshi Hashiguchi, Masatsugu Hiraki, Hirokazu Noshiro, Kohji Miyazaki.   

Abstract

The hypoxic marker carbonic anhydrase (CA) IX has been recognized as a tumor-associated protein and is essential for cancer development. However, because CA IX expression does not always correlate with hypoxia, its regulatory mechanism remains unclear. The objective of the present study was to clarify the role and regulation of CA IX expression in gastric cancer. The immunohistochemical expression of CA IX and hypoxia-inducible factor-1α was assessed in 77 patients with gastric cancer. A methylation-sensitive restriction enzyme method was used to quantify site-specific methylation at -74 bp in the CA9 promoter in tissue from patients with gastric cancer and in corresponding normal tissue. CA9 expression in cell lines was strongly dependent on methylation status but not hypoxic stimuli. In tissue from patients with gastric cancer, the quantity of methylation was significantly correlated with the protein expression (P = 0.003). Moreover, the methylation value was significantly lower in intestinal-type compared with diffuse-type cancer (P = 0.003). Compared with normal mucosa, intestinal-type cancer demonstrated significant hypomethylation, whereas diffuse-type cancer exhibited hypermethylation. In conclusion, expression of CA IX in gastric cancer is predominantly regulated by methylation of a single CpG rather than by hypoxia. Furthermore, epigenetic alterations in CA9 differ between the intestinal and diffuse types of gastric cancer.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21281785      PMCID: PMC3069889          DOI: 10.1016/j.ajpath.2010.10.010

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

Review 1.  Causes and consequences of tumour acidity and implications for treatment.

Authors:  M Stubbs; P M McSheehy; J R Griffiths; C L Bashford
Journal:  Mol Med Today       Date:  2000-01

2.  Hypoxia-inducible expression of tumor-associated carbonic anhydrases.

Authors:  C C Wykoff; N J Beasley; P H Watson; K J Turner; J Pastorek; A Sibtain; G D Wilson; H Turley; K L Talks; P H Maxwell; C W Pugh; P J Ratcliffe; A L Harris
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

3.  Expression of MaTu-MN protein in human tumor cultures and in clinical specimens.

Authors:  J Závada; Z Závadová; S Pastoreková; F Ciampor; J Pastorek; V Zelník
Journal:  Int J Cancer       Date:  1993-05-08       Impact factor: 7.396

4.  Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts.

Authors:  S Pastoreková; S Parkkila; A K Parkkila; R Opavský; V Zelník; J Saarnio; J Pastorek
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

Review 5.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

6.  Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.

Authors:  Lydia Jakubicková; Zuzana Biesová; Silvia Pastoreková; Richard Kettmann; Jaromír Pastorek
Journal:  Int J Oncol       Date:  2005-04       Impact factor: 5.650

Review 7.  Control of gut differentiation and intestinal-type gastric carcinogenesis.

Authors:  Yasuhito Yuasa
Journal:  Nat Rev Cancer       Date:  2003-08       Impact factor: 60.716

8.  Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.

Authors:  Ann Driessen; Willy Landuyt; Sylvia Pastorekova; Johnny Moons; Laurence Goethals; Karin Haustermans; Philippe Nafteux; Freddy Penninckx; Karel Geboes; Toni Lerut; Nadine Ectors
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

Review 9.  Human carbonic anhydrases and carbonic anhydrase deficiencies.

Authors:  W S Sly; P Y Hu
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

Review 10.  Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer.

Authors:  C P S Potter; A L Harris
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

View more
  18 in total

1.  Carbonic anhydrases II, IX, and XII in Barrett's esophagus and adenocarcinoma.

Authors:  Minna Nortunen; Heikki Huhta; Olli Helminen; Seppo Parkkila; Joonas H Kauppila; Tuomo J Karttunen; Juha Saarnio
Journal:  Virchows Arch       Date:  2018-07-31       Impact factor: 4.064

2.  Nicotine induced CpG methylation of Pax6 binding motif in StAR promoter reduces the gene expression and cortisol production.

Authors:  Tingting Wang; Man Chen; Lian Liu; Huaiyan Cheng; You-E Yan; Ying-Hong Feng; Hui Wang
Journal:  Toxicol Appl Pharmacol       Date:  2011-09-24       Impact factor: 4.219

3.  Carbonic Anhydrases II and IX in Non-ampullary Duodenal Adenomas and Adenocarcinoma.

Authors:  Minna Nortunen; Seppo Parkkila; Juha Saarnio; Heikki Huhta; Tuomo J Karttunen
Journal:  J Histochem Cytochem       Date:  2021-10-12       Impact factor: 2.479

4.  Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer.

Authors:  David J Stewart; Maria I Nunez; Carmen Behrens; Diane Liu; Yan Heather Lin; J Jack Lee; Jack Roth; John Heymach; Stephen G Swisher; Waun Ki Hong; Ignacio Ivan Wistuba
Journal:  J Thorac Oncol       Date:  2014-05       Impact factor: 15.609

5.  Genetic and epigenetic alterations of steroidogenic factor‑1 in ovarian tumors.

Authors:  Sarah Miller; Nobel Bhasin; Heather Urrego; Krzysztof Moroz; Brian G Rowan; Meera S Ramayya; Nick M Makridakis
Journal:  Int J Oncol       Date:  2012-12-28       Impact factor: 5.650

Review 6.  Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancers.

Authors:  G Ilardi; N Zambrano; F Merolla; M Siano; S Varricchio; M Vecchione; G De Rosa; M Mascolo; S Staibano
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

7.  DNA hypomethylation-mediated overexpression of carbonic anhydrase 9 induces an aggressive phenotype in ovarian cancer cells.

Authors:  Hye Youn Sung; Woong Ju; Jung-Hyuck Ahn
Journal:  Yonsei Med J       Date:  2014-11       Impact factor: 2.759

8.  Carbonic anhydrase IX is a critical determinant of pulmonary microvascular endothelial cell pH regulation and angiogenesis during acidosis.

Authors:  Ji Young Lee; Mikhail Alexeyev; Natalya Kozhukhar; Viktoriya Pastukh; Roderica White; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-04-05       Impact factor: 5.464

9.  The co-expression of functional gastric proteins in dynamic gastric diseases and its clinical significance.

Authors:  Qian Xu; Li-Ping Sun; Ben-Gang Wang; Jing-Wei Liu; Ping Li; Cai-Yun He; Yuan Yuan
Journal:  BMC Clin Pathol       Date:  2013-08-09

10.  CMTM3 inhibits human testicular cancer cell growth through inducing cell-cycle arrest and apoptosis.

Authors:  Zesong Li; Jun Xie; Jianting Wu; Wenjie Li; Liping Nie; Xiaojuan Sun; Aifa Tang; Xianxin Li; Ren Liu; Hongbing Mei; Feng Wang; Zhiping Wang; Yaoting Gui; Zhiming Cai
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.